Skip to main content
Erschienen in:

28.09.2023 | Original Article

Dynamics of perioperative pancreatic exocrine function in patients undergoing reconstruction after gastrectomy for gastric cancer

verfasst von: Takashi Nakayama, Katsutoshi Shoda, Kensuke Shiraishi, Shinji Furuya, Naohiro Hosomura, Hidenori Akaike, Yoshihiko Kawaguchi, Hidetake Amemiya, Hiromichi Kawaida, Daisuke Ichikawa

Erschienen in: Surgery Today | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Each method of reconstruction after gastrectomy results in a change in the digestive and absorptive status. However, there are few reports on the changes in pancreatic exocrine function after gastrectomy. We conducted this study to investigate the dynamics of pancreatic exocrine function after gastrectomy according to the method of reconstruction performed.

Methods

The subjects of this study were 45 patients who underwent pancreatic exocrine function tests preoperatively and postoperatively, from among all patients who underwent gastrectomy for gastric cancer at our hospital between September, 2020 and March, 2022. We assessed pancreatic exocrine function using the Pancreatic Function Diagnostant (PFD) test.

Result

The mean preoperative PFD test result values for the distal gastrectomy (DG) Billroth I reconstruction (B–I) group and the DG Roux-en-Y reconstruction (R–Y) group were 62.6 and 67.3 (p = 0.36), respectively, and the mean postoperative PFD test result values for each group were 65.8 and 46.9 (p = 0.0094), respectively. A significant decrease in postoperative pancreatic function was observed in the DG R-Y group but not in the DG B–I group. The logistic regression analysis identified that age and the R–Y group were significantly correlated with a 10% decrease in the PFD value after gastrectomy.

Conclusions

Our study suggests that R–Y reconstruction may result in more impaired pancreatic exocrine function than B–I reconstruction.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.CrossRefPubMed Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.CrossRefPubMed
2.
Zurück zum Zitat Piessen G, Triboulet JP, Mariette C. Reconstruction after gastrectomy: which technique is best? J Visc Surg. 2010;147(5):e273–83.CrossRefPubMed Piessen G, Triboulet JP, Mariette C. Reconstruction after gastrectomy: which technique is best? J Visc Surg. 2010;147(5):e273–83.CrossRefPubMed
3.
Zurück zum Zitat Brägelmann R, Armbrecht U, Rosemeyer D, Schneider B, Zilly W, Stockbrügger RW. Nutrient malassimilation following total gastrectomy. Scand J Gastroenterol Suppl. 1996;218:26–33.CrossRefPubMed Brägelmann R, Armbrecht U, Rosemeyer D, Schneider B, Zilly W, Stockbrügger RW. Nutrient malassimilation following total gastrectomy. Scand J Gastroenterol Suppl. 1996;218:26–33.CrossRefPubMed
4.
Zurück zum Zitat Aoyama T, Yoshikawa T, Shirai J, Hayashi T, Yamada T, Tsuchida K, et al. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol. 2013;20(6):2000–6.CrossRefPubMed Aoyama T, Yoshikawa T, Shirai J, Hayashi T, Yamada T, Tsuchida K, et al. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol. 2013;20(6):2000–6.CrossRefPubMed
5.
Zurück zum Zitat Straatman J, Wiegel J, van der Wielen N, Jansma EP, Cuesta MA, van der Peet DL. Systematic Review of Exocrine Pancreatic Insufficiency after Gastrectomy for Cancer. Dig Surg. 2017;34(5):364–70.CrossRefPubMed Straatman J, Wiegel J, van der Wielen N, Jansma EP, Cuesta MA, van der Peet DL. Systematic Review of Exocrine Pancreatic Insufficiency after Gastrectomy for Cancer. Dig Surg. 2017;34(5):364–70.CrossRefPubMed
6.
Zurück zum Zitat Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015;18(1):147–58.CrossRefPubMed Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015;18(1):147–58.CrossRefPubMed
7.
Zurück zum Zitat Kinoshita T, Honda M, Matsuki A, Enomoto N, Aizawa M, Nunobe S, et al. Billroth-I vs Roux-en-Y after distal gastrectomy: A comparison of long-term nutritional status and survival rates from a large-scale multicenter cohort study. Ann Gastroenterol Surg. 2020;4(2):142–50.CrossRefPubMedPubMedCentral Kinoshita T, Honda M, Matsuki A, Enomoto N, Aizawa M, Nunobe S, et al. Billroth-I vs Roux-en-Y after distal gastrectomy: A comparison of long-term nutritional status and survival rates from a large-scale multicenter cohort study. Ann Gastroenterol Surg. 2020;4(2):142–50.CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat Armbrecht U, Lundell L, Lindstedt G, Stockbruegger RW. Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand. 1987;154(1):37–41. Armbrecht U, Lundell L, Lindstedt G, Stockbruegger RW. Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand. 1987;154(1):37–41.
10.
Zurück zum Zitat Paik CN, Choi MG, Lim CH, Park JM, Chung WC, Lee KM. The role of small intestinal bacterial overgrowth in postgastrectomy patients. Neurogastroenterol Motil. 2011;23(5):e191–6.CrossRefPubMed Paik CN, Choi MG, Lim CH, Park JM, Chung WC, Lee KM. The role of small intestinal bacterial overgrowth in postgastrectomy patients. Neurogastroenterol Motil. 2011;23(5):e191–6.CrossRefPubMed
11.
Zurück zum Zitat Gullo L, Costa PL, Ventrucci M, Mattioli S, Viti G, Labò G. Exocrine pancreatic function after total gastrectomy. Scand J Gastroenterol. 1979;14(4):401–7.PubMed Gullo L, Costa PL, Ventrucci M, Mattioli S, Viti G, Labò G. Exocrine pancreatic function after total gastrectomy. Scand J Gastroenterol. 1979;14(4):401–7.PubMed
12.
Zurück zum Zitat Friess H, Böhm J, Müller MW, Glasbrenner B, Riepl RL, Malfertheiner P, Büchler MW. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol. 1996;91(2):341–7.PubMed Friess H, Böhm J, Müller MW, Glasbrenner B, Riepl RL, Malfertheiner P, Büchler MW. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol. 1996;91(2):341–7.PubMed
13.
Zurück zum Zitat Moriyoshi Y, Shiratori K, Watanabe S. Potentiating effect of CCK and secretin on rat exocrine pancreas and its cholinergic dependence. Pancreas. 1991;6(5):603–8.CrossRefPubMed Moriyoshi Y, Shiratori K, Watanabe S. Potentiating effect of CCK and secretin on rat exocrine pancreas and its cholinergic dependence. Pancreas. 1991;6(5):603–8.CrossRefPubMed
14.
Zurück zum Zitat Shiratori K, Watanabe S, Maruyama M, Ohta Y, Kurokawa K, Takeuchi T. Plasma secretin levels and gastric pH after a meal. Jpn J Gastroenterol. 1983;80(2):156–9. Shiratori K, Watanabe S, Maruyama M, Ohta Y, Kurokawa K, Takeuchi T. Plasma secretin levels and gastric pH after a meal. Jpn J Gastroenterol. 1983;80(2):156–9.
15.
Zurück zum Zitat Sekine T, Kameyama J, Sasaki I, Imamura M, Miyakawa H, Inui M, et al. An evaluation of pylorus-preserving gastrectomy for gastric ulcer. Jpn J Gastroenterol Surg. 1980;13(12):1336–41.CrossRef Sekine T, Kameyama J, Sasaki I, Imamura M, Miyakawa H, Inui M, et al. An evaluation of pylorus-preserving gastrectomy for gastric ulcer. Jpn J Gastroenterol Surg. 1980;13(12):1336–41.CrossRef
16.
Zurück zum Zitat Watanabe S, Shiratori K, Takeuchi T, Chey WY, You CH, Chang TM. Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects. Dig Dis Sci. 1986;31(9):919–24.CrossRefPubMed Watanabe S, Shiratori K, Takeuchi T, Chey WY, You CH, Chang TM. Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects. Dig Dis Sci. 1986;31(9):919–24.CrossRefPubMed
17.
Zurück zum Zitat DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288(16):813–5.CrossRefPubMed DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288(16):813–5.CrossRefPubMed
Metadaten
Titel
Dynamics of perioperative pancreatic exocrine function in patients undergoing reconstruction after gastrectomy for gastric cancer
verfasst von
Takashi Nakayama
Katsutoshi Shoda
Kensuke Shiraishi
Shinji Furuya
Naohiro Hosomura
Hidenori Akaike
Yoshihiko Kawaguchi
Hidetake Amemiya
Hiromichi Kawaida
Daisuke Ichikawa
Publikationsdatum
28.09.2023
Verlag
Springer Nature Singapore
Erschienen in
Surgery Today / Ausgabe 5/2024
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-023-02746-1

Neu im Fachgebiet Chirurgie

Akute Cholezystitis bei multimorbiden Älteren: Operation nicht sofort ausschließen!

Bei älteren, multimorbiden Menschen mit akuter Cholezystitis wird eine Operation häufig nicht erwogen. Eine Studie aus Philadelphia zeigt nun jedoch, dass auch diese Patientinnen und Patienten von einer chirurgischen Therapie profitieren können.

Was geschehen muss, damit Prähabilitation in die Leitlinien kommt

Eine Prähabilitation vor einem viszeralchirurgischen Eingriff ist Experten zufolge äußerst sinnvoll, dennoch wird sie in Leitlinien derzeit nicht empfohlen. Beim DCK erklärte Prof. Tim Vilz aus Bonn, woran das liegt und was benötigt wird, um die Situation zu ändern.

Thoracic-Outlet-Syndrom nur in Ausnahmefällen operieren!

Das Thoracic-Outlet-Syndrom erfordert nur in ganz bestimmten Fällen ein operatives Vorgehen. Beim DCK wurde vor schwerwiegenden Komplikationen des anspruchsvollen Eingriffs gewarnt.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.